ArticleInvestigational new drugs2019

Correction to: Phase II study of sunitinib in Japanese patients with unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumor.

Tetsuhide Ito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.